Navigation Links
Bayer HealthCare Launches Hemophilia Self-Infusion Training Program
Date:7/9/2009

f-infusion training program or Kogenate(R) FS, please visit www.kogenatefs.com.

INDICATIONS

Kogenate(R) FS, antihemophilic factor (recombinant), is a recombinant factor VIII treatment indicated for the control and prevention of bleeding episodes and peri-operative management in adults and children (0-16 years) with hemophilia A. Kogenate FS is also indicated for routine prophylaxis to reduce the frequency of bleeding episodes and the risk of joint damage in children with hemophilia A with no preexisting joint damage.

IMPORTANT SAFETY INFORMATION ABOUT KOGENATE(R) FS

The most serious adverse reactions are systemic hypersensitivity reactions and the development of high titer inhibitors necessitating alternative treatments to AHF. The most common adverse reactions observed in clinical trials were inhibitor formation in previously untreated or minimally treated patients, skin-associated hypersensitivity reactions, infusion site reactions, and central venous access device (CVAD) line-associated infections.

Kogenate(R) FS is contraindicated in patients who have manifested life-threatening immediate hypersensitivity reactions, including anaphylaxis, to the product or its components, including mouse or hamster proteins.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Please see the full prescribing information for important risk and use information at www.kogenatefs.com.

About Hemophilia A

Hemophilia A, also known as factor VIII deficiency or classic hemophilia, is lar
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Bayer CropScience and Monsanto Sign Cross Licensing Agreement on Herbicide Tolerance Traits in Rapeseed/Canola
2. Bayer Diabetes Care Launches A1CNow(R) SELFCHECK, a New A1C Monitor for At-Home Use
3. Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Non-Small Cell Lung Cancer
4. AUDIO from Medialink, Bayer Healthcare and Onyx Pharmaceuticals: Facts About Hepatitis
5. Bayer to Present Data on Development Compound BAY 73-4506 at 45th Annual Meeting of the American Society of Clinical Oncology
6. Now Available: Bayer Diabetes Cares CONTOUR(R) Meters in Midnight Blue and Orange Burst
7. Bayer CropScience Welcomes New Emergency Services Leader to the Institute Site
8. J&J, Schering-Plough, Novartis, Bayer vie for Top Honors at the Premier OTC / Healthcare Ad Awards
9. Bayer HealthCare Marks 20th Anniversary of World Hemophilia Day With Euro 250,000 Contribution to the World Federation of Hemophilia
10. Nick Jonas and Bayer Diabetes Care Launch Creativity Contest to Encourage Kids With Diabetes to Express Their Simple Win
11. Bayer Awards $200,000 to National Science Teachers Association to Nurture Early-Career Science Teachers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... New York, NY (PRWEB) August 30, 2014 ... headlines will quickly ensue, as happened on Wednesday, August 27th, ... a successful attack on JPMorgan Chase & Co and ... that the FBI is actually investigating attacks on seven ... and how they may be affected, and the buzz quickly ...
(Date:8/30/2014)... As 500 Zoloft lawsuits pending ligation contend the SSRI andidepressant ... & Schulte LLC recently learned of a remand issued by ... in the Zoloft lawsuits was granted to 25 plaintiffs ... one SSRI lawsuit filed jointly under MDL 2342 ... sent back to the Missouri state court in which it ...
(Date:8/30/2014)... 30, 2014 Barton Associates, an industry ... tenens company , announces a new office location in ... Associates is headquartered in Peabody, MA, with additional staffing ... TX; and Jupiter, FL. , Barton Associates made the ... physician shortage crisis affecting the United States, a crisis ...
(Date:8/30/2014)... Spain Saturday 30 August 2014: The first ... patients with acute coronary syndromes (ACS) are published ... position paper was written jointly by the European ... Association (ACCA) and the European Association of Percutaneous ... , Professor Bulent Gorenek (Turkey), chairperson of the ...
(Date:8/30/2014)... Spain Saturday 30 August 2014: A new ... (HCM) identifies candidates for implantable cardioverter defibrillators (ICDs) ... at ESC Congress by Task Force Chairperson Professor ... on Diagnosis and Management of Hypertrophic Cardiomyopathy" are ... Journal (1) and on the ESC Website. ...
Breaking Medicine News(10 mins):Health News:Big Name Bank Hacks Highlight the Importance of Regular Testing and Effective Emergency Response 2Health News:Big Name Bank Hacks Highlight the Importance of Regular Testing and Effective Emergency Response 3Health News:Big Name Bank Hacks Highlight the Importance of Regular Testing and Effective Emergency Response 4Health News:Big Name Bank Hacks Highlight the Importance of Regular Testing and Effective Emergency Response 5Health News:Group of Plaintiffs in Zoloft Lawsuit Alleging SSRI Caused Birth Defect Are Granted Remand 2Health News:Group of Plaintiffs in Zoloft Lawsuit Alleging SSRI Caused Birth Defect Are Granted Remand 3Health News:Group of Plaintiffs in Zoloft Lawsuit Alleging SSRI Caused Birth Defect Are Granted Remand 4Health News:Group of Plaintiffs in Zoloft Lawsuit Alleging SSRI Caused Birth Defect Are Granted Remand 5Health News:Barton Associates to Open a New Office Location in Keene, NH 2Health News:First multidisciplinary recommendations on management of arrhythmias in ACS patients 2Health News:Sudden death predictor identifies ICD candidates in new ESC Guidelines 2
... ... to help anyone seeking improved health and wellness. Learn how to improve the look and ... enhance your physical appearance with information provided on this new Web site. , ... (PRWEB) June 17, 2010 -- A new Web site has ...
... , ... to announce the addition of Lázaro Garza as an Engineered Sales Representative for Ellsworth Adhesives ... ... announce the addition of Lázaro Garza as an Engineered Sales Representative for Ellsworth Adhesives S. ...
... Italy, Thursday 17 June 2010: Smoking cigarettes is a ... may have a negative impact on the effectiveness of ... these treatments, according to results of two studies presented ... European League Against Rheumatism in Rome, Italy. A further ...
... ... in 2010 Focusing on Professional, Olympic, and Recreational Athletes , ... Washington, D.C. (PRWEB) June 17, 2010 -- Athletes for Hope ... Agassi, Muhammad Ali, and Lance Armstrong for the purpose of inspiring all athletes to engage ...
... ... Receives Seal of Approval from Industry Voice , ... Fishkill, NY (PRWEB) June 17, 2010 -- Dear ... dentistry and oral health, has announced that the International Congress of Oral Implantologists ...
... ... released Semantics Platform v 2.0 which is made up of three products: Semantics.Datacenter, Semantics.Server, ... product offerings in industry standard benchmark tests (Berlin 100M 5/25/10). , ... Brattleboro, VT (PRWEB) June ...
Cached Medicine News:Health News:New Web Site Provides Helpful Exercise and Nutrition Tips 2Health News:Ellsworth Adhesives Announces New International Engineered Sales Representative 2Health News:Smoking cigarettes is a predictor of RA and may negatively impact on efficacy of anti-TNFs 2Health News:Smoking cigarettes is a predictor of RA and may negatively impact on efficacy of anti-TNFs 3Health News:Athletes for Hope Awarded $2 Million Grant by Kellogg Foundation 2Health News:Athletes for Hope Awarded $2 Million Grant by Kellogg Foundation 3Health News:International Congress of Oral Implantologists (ICOI) Joins Other Professional Organizations Endorsing Dear Doctor Magazine 2Health News:Intellidimension Releases New Version of Semantic Web Technologies 2
(Date:8/29/2014)... 29, 2014 The Competitive Intelligence (CI) function ... changes. CI leaders who adjust will succeed, and those ... new Best Practices, LLC study CI leaders from 32 ... - Use secondary research whenever possible - ... - Internal staff who are creative thinkers provide ...
(Date:8/29/2014)... Aug. 29, 2014 Pomerantz LLP has filed ... the "Company") (NASDAQ: EDAP ) and certain ... States District Court, Southern District of New ... behalf of a class consisting of all persons or ... and July 30, 2014, inclusive (the "Class Period"). This class ...
(Date:8/29/2014)... Aug. 29, 2014   Mast Therapeutics, Inc. ... announced today that Santosh Vetticaden, Chief Medical Officer ... Company, for personal reasons, in mid-September.  Edwin ... of Aires Pharmaceuticals, which Mast acquired earlier this ... the Company,s interim Chief Medical Officer.  Dr. Parsley ...
Breaking Medicine Technology:Using the Competitive Intelligence Function to Drive Better Business Decisions in the Pharmaceutical Sector 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 3Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4
... Md., Jan. 31, 2011 Vanda Pharmaceuticals Inc. (Vanda) ... on the development and commercialization of products for central ... a universal shelf registration statement on Form S-3 with ... effective by the SEC, the shelf registration statement will ...
... Technologies, Inc. (the "Company") (Nasdaq: CMED ), ... announced that it will report its unaudited financial results ... before the U.S. market opens on February 18, 2011. ... 2011. The Company,s senior management will ...
Cached Medicine Technology:Vanda Pharmaceuticals Files Shelf Registration Statement 2Vanda Pharmaceuticals Files Shelf Registration Statement 3Vanda Pharmaceuticals Files Shelf Registration Statement 4China Medical Technologies to Announce Results for the Third Fiscal Quarter Ended December 31, 2010 on February 18, 2011 2
... a combination of innovative design, consistently reliable ... I-125 implant an ideal choice for your ... every BrachySource I-125 implant order is backed ... required by clinicians who must meet the ...
... BrachySource iodine-125 implant is a combination of ... visibility that makes BrachySource I-125 implant an ... can be confident that every BrachySource I-125 ... management services which is required by clinicians ...
The silicone Tractfinder provides excellent fluoroscopic visualization. Manipulation of the movable core guidewire flexes the tapered proximal tip for maximum control in negotiating a tortuous ureter...
... Used for temporary internal drainage from the ... of a stricture. The segment with no ... lumen while preventing ingrowth of the ureteral ... peel-open packages. Intended for one-time use. CAUTION: ...
Medicine Products: